U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07473076) titled 'REgulating Pain Through Neurofeedback in infLammatory Bowel diseasE and Musculoskeletal Dysfunction' on Nov. 18, 2025.
Brief Summary: Clinical trial with a CE-marked medical device. Use as indicated in patients with chronic inflammatory bowel disease and musculoskeletal pain. The aim of this study is to evaluate the efficacy of neurofeedback therapy in managing musculoskeletal pain in patients with chronic inflammatory bowel disease.
Study Start Date: Feb. 25
Study Type: INTERVENTIONAL
Condition:
Inflammatory Bowel Diseases
Intervention:
BEHAVIORAL: Experimental group
Experimental psychotherapy treatment with 8 sessions of a...